UNSPSC 51382503: Tribenoside

This classification denotes a non-steroidal anti-inflammatory agent with the molecular formula C29H34O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z7N0Y673NU, chemically known as glucofuranoside, ethyl-3,5,6-tri-o-benzyl-, d- but generally known as tribenoside, which bears US NIH Compound Identifier 25145. European Medicines Agency schedules Tribenoside in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11260MIG.

UNSPSC 51382503 Tribenoside, a Commodity code, describes pharmaceutical products for treatment and management of specific medical conditions, though the recent solicitation activity tagged to this code does not align with the code's nominal scope—the identified opportunity procures naloxone and drug deactivation systems rather than tribenoside formulations. State and local purchasing under this code tier, when properly matched, typically targets specialized pharmaceuticals for health departments, county health systems, and municipal emergency services. The mismatch between the code classification and the actual procurement suggests that either the opportunity was miscoded or that tribenoside procurement does not currently generate measurable state and local solicitation volume.

Recent activity shows minimal relevant procurement signals. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, to procure naloxone and safe drug deactivation systems—1,900 units and 800 units annually respectively—with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023, though this opportunity's substance does not reflect tribenoside procurement. The geographic and issuing-body patterns cannot be reliably characterized from a single misaligned solicitation. No other recent opportunities under this Commodity code appear in the current record, indicating either very limited state and local purchasing activity for tribenoside or a consistent classification gap in how jurisdictions tag pharmaceutical procurements to UNSPSC codes.